ASSOCIATION OF ULTRASOUND FINDINGS AND BIOCHEMICAL TESTS OF LIVER WITH OR WITHOUT ESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC LIVER DISEASE
Keywords:
Esophageal varices, chronic liver disease, ultrasound imaging.Abstract
To compare liver function tests, complete blood count parameters, and liver morphology between patients with and without esophageal varices in chronic liver disease. This observational comparative study was conducted in the Outpatients Department of Patel Hospital, Karachi, using a non-probability consecutive sampling method over six months. The study included 100 patients, divided into two groups: 60 patients with EV and 40 patients without varices, aged 30 to 55, both male and female. Patients underwent clinical examinations, laboratory tests, and abdominal ultrasonography, followed by EGD screening to identify esophageal varices (EV), with grading based on size. An independent sample t-test, a Mann-Whitney U test, and a chi-square test were used to compare groups with and without EV, with significance set at p < 0.05. The study findings showed that the mean age was similar between the groups, with no significant gender differences. Hepatitis C virus (HCV) was the most common cause of chronic liver disease in both groups. Patients with EV had significantly higher INR, lower albumin levels, and larger portal vein diameters compared to those without EV. The Child-Pugh score was higher in the EV group (7.33 ± 1.96), indicating more severe liver dysfunction. Liver ultrasonography revealed no significant difference in texture, but there was a significant difference in liver margin irregularities and size. Additionally, patients with EV had lower hemoglobin and platelet counts, longer prothrombin times, and higher aspartate aminotransferase (AST) levels.
Downloads
References
Sure! Here's the list of references with the formatting removed:
Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054.
Yoon H, Shin HJ, Kim MJ, Han SJ, Koh H, Kim S, et al. Predicting gastroesophageal varices through spleen magnetic resonance elastography in pediatric liver fibrosis. World J Gastroenterol. 2019 Jan 21;25(3):367-377. doi: 10.3748/wjg.v25.i3.367.
Nery F, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, et al. Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study. Aliment Pharmacol Ther. 2019 Mar;49(5):582-588. doi: 10.1111/apt.15137.
Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep. 2003;52(9):1-85.
Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Eng J Med. 2010;362(9):823-832. doi: 10.1056/NEJMra0901512.
Hong WD, Dong LM, Jiang ZC, Zhu QH, Jin SQ. Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis. Clinics (Sao Paulo). 2011;66(1):119-124. doi: 10.1590/s1807-59322011000100021.
Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;102(9):2086-2102. doi: 10.1002/hep.21907.
Giuffrè M, Macor D, Masutti F, Abazia C, Tinè F, Bedogni G, et al. Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis. Ann Hepatol. 2020;19(1):53-61. doi: 10.1016/j.aohep.2019.09.004.
Devrajani BR, Soomro AA, Attra KM. Variceal bleeding and its dependence on portal vein size in liver cirrhotic patients. World J Med Sci. 2009;4:50-53. ISSN 1817-3055.
Elkenawy YN, Elarabawy RA, Ahmed LM, Elsawy AA. Portal vein flow velocity as a possible fast noninvasive screening tool for esophageal varices in cirrhotic patients. JGH Open. 2020 Jan 22;4(4):589-594. doi: 10.1002/jgh3.12301.
Geleto G, Getnet W, Tewelde T. Mean Normal Portal Vein Diameter Using Sonography among Clients Coming to Radiology Department of Jimma University Hospital, Southwest Ethiopia. Ethiop J Health Sci. 2016 May;26(3):237-242. doi: 10.4314/ejhs.v26i3.6.
Shastri M, Kulkarni S, Patell R, Jasdanwala S. Portal vein Doppler: a tool for non-invasive prediction of esophageal varices in cirrhosis. J Clin Diagn Res. 2014 Jul;8(7):MC12-5. doi: 10.7860/JCDR/2014/8571.4589.
Thabut D, Moreau R, Lebrec D. Noninvasive assessment of portal hypertension in patients with cirrhosis. Hepatology. 2011;53(2):683-694. doi: 10.1002/hep.24129.
Charoenchue P, Na Chiangmai W, Amantakul A, Wanchaitanawong W, Chitapanarux T, Pojchamarnwiputh S. Prediction of Esophageal Varices in Viral Hepatitis C Cirrhosis: Performance of Combined Ultrasonography and Clinical Predictors. Int J Biomed Imaging. 2023 Sep 15;2023:7938732. doi: 10.1155/2023/7938732.
Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol. 2006;101(11):2511-2519. doi: 10.1111/j.1572-0241.2006.00874.x.
Deng H, Qi X, Peng Y, Li J, Li H, Zhang Y, et al. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit. 2015 Dec 20;21:3961-3977. doi: 10.12659/msm.895005.
Schwarzenberger E, Meyer T, Golla V, Sahdala NP, Min AD. Utilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2010 Feb;44(2):146-150. doi: 10.1097/MCG.0b013e3181a745ff.
Karatzas A, Konstantakis C, Aggeletopoulou I, Kalogeropoulou C, Thomopoulos K, Triantos C. Noninvasive screening for esophageal varices in patients with liver cirrhosis. Ann Gastroenterol. 2018 May-Jun;31(3):305-314. doi: 10.20524/aog.2018.0241.
Mahassadi AK, Bathaix FY, Assi C, Bangoura AD, Allah-Kouadio E, Kissi HY, et al. Usefulness of noninvasive predictors of oesophageal varices in black african cirrhotic patients in Côte d’Ivoire (west africa). Gastroenterology research and practice. 2012;2012:216390. doi: 10.1155/2012/216390.
Tsoris A, Marlar CA. Use of the Child Pugh Score in Liver Disease. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542308/
Katwal S, Ansari MA, Suwal S, Rayamajhi S, Ghimire P, Ghimire A. Measurement of portal vein indices and splenic index by ultrasound and their association with gastroesophageal varices in cirrhosis of liver. Ann Med Surg (Lond). 2023 Nov 7;85(12):5926-5931. doi: 10.1097/MS9.0000000000001483.
Khan J, Rabbani A, Ali S, Dar UF, Riaz H, Nayyar U, et al. Frequency of Esophageal Varices and Comparison of Serum Albumin levels with and without Esophageal Varices in Patients Presenting with Chronic Liver Disease. P J M H S. 2016;10(1):127-129.
Khan IA, Saleem A, Yousaf S, Sarfraz M, Alam MA, Mohsin A. Characteristics and Associations of Esophageal Varices in Liver Cirrhosis Patients. P J M H S. 2020;14(2):365-367.
Afzal M, Tarar SH, Shah SMA. Spectrum of Endoscopic Findings in Patients with Liver Cirrhosis due to Chronic Viral Hepatitis. Pak J Med Health Sci. 2018;12(1):10-13.
Malghani WS, Malik R, Chaudhary FMD, Tameez Ud Din A, Shahid M, Ahmad S, et al. Spectrum of Endoscopic Findings in Patients of Upper Gastrointestinal Bleeding at a Tertiary Care Hospital. Cureus. 2019 Apr 29;11(4):e4562. doi: 10.7759/cureus.4562.
Chen CY, Wu CJ, Pan CF, Chen HH, Chen YW. Influence of Age on Critically Ill Patients with Cirrhosis. International J Gerontology. 2015;9(4):233-238. doi: 10.1016/j.ijge.2014.10.003.
Duah A, Nkrumah KN, Tachi K. Oesophageal varices in patients with liver cirrhosis: evaluation of the utility of clinical parameters in non-invasive diagnosis. Ghana Med J. 2018 Jun;52(2):69-74. doi: 10.4314/gmj.v52i2.4.
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.